[go: up one dir, main page]

BR9106117A - Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto - Google Patents

Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto

Info

Publication number
BR9106117A
BR9106117A BR919106117A BR9106117A BR9106117A BR 9106117 A BR9106117 A BR 9106117A BR 919106117 A BR919106117 A BR 919106117A BR 9106117 A BR9106117 A BR 9106117A BR 9106117 A BR9106117 A BR 9106117A
Authority
BR
Brazil
Prior art keywords
antraquinone
inhibition
replaced
compound
pharmaceutical composition
Prior art date
Application number
BR919106117A
Other languages
English (en)
Inventor
Jack B Jiang
Mary George Johnson
Original Assignee
Sphinx Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphinx Pharma Corp filed Critical Sphinx Pharma Corp
Publication of BR9106117A publication Critical patent/BR9106117A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
    • C07C225/36—Amino anthraquinones the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR919106117A 1990-11-02 1991-10-30 Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto BR9106117A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60824890A 1990-11-02 1990-11-02
US07/609,416 US5141957A (en) 1990-11-02 1990-11-05 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
PCT/US1991/008030 WO1992007558A1 (en) 1990-11-02 1991-10-30 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c

Publications (1)

Publication Number Publication Date
BR9106117A true BR9106117A (pt) 1993-03-09

Family

ID=27085707

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106117A BR9106117A (pt) 1990-11-02 1991-10-30 Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto

Country Status (11)

Country Link
US (1) US5141957A (pt)
EP (1) EP0509088A4 (pt)
JP (1) JPH05505829A (pt)
KR (1) KR920703512A (pt)
AU (1) AU641581B2 (pt)
BR (1) BR9106117A (pt)
CA (1) CA2072884A1 (pt)
FI (1) FI923031A7 (pt)
HU (1) HUT64296A (pt)
NO (1) NO922601D0 (pt)
WO (1) WO1992007558A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA936396B (en) * 1992-09-08 1994-06-13 Univ Vermont 4-Substituted 6,9-bis(substituted-amino)benzo[g] isoquinoline-5,10,diones
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
WO1995034307A1 (en) * 1994-06-14 1995-12-21 Sloan-Kettering Institute For Cancer Research Ceramide-activated protein kinase and methods of use of effectors
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
US6376467B1 (en) * 1998-10-09 2002-04-23 The Regents Of The University Of California Use of inhibitors of protein kinase C epsilon to treat pain
JP2002519391A (ja) * 1998-07-06 2002-07-02 オー． メッシング，ロバート 痛みを処置するための、プロテインキナーゼｃイプシロンの阻害剤の使用
US6717030B2 (en) * 1998-07-06 2004-04-06 The Regents Of The University Of California Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
CN102266272B (zh) * 2002-11-27 2012-12-26 Dmi生物科学公司 一种个人护理组合物及其产品
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
EP1670497A4 (en) 2003-09-16 2009-07-15 Garvan Inst Med Res METHOD FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C EPSILON (PKC Ε) AND METHOD FOR TREATING THEREOF CONVERTING DERIVED GLUCOSE METABOLISM
US8592368B2 (en) 2003-12-19 2013-11-26 University Of South Florida JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
US8158586B2 (en) * 2005-04-11 2012-04-17 Pharmagap Inc. Inhibitors of protein kinases and uses thereof
TW200803849A (en) 2005-09-16 2008-01-16 Schering Corp Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
EP2124987A4 (en) 2007-01-19 2012-05-02 Kai Pharmaceuticals Inc METHOD OF USE OF EPSILON HEMMER COMPOUNDS FOR PAIN LIFTING
EP2942060A1 (en) 2009-09-29 2015-11-11 Joslin Diabetes Center, Inc. Use of Protein Kinase C Delta (PKCD) Inhibitors to Treat Diabetes, Obesity and, Hepatic Steatosis
AU2015256266B2 (en) 2014-05-05 2019-01-17 Emory University BH4 antagonists and methods related thereto

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1540733A (en) * 1923-10-25 1925-06-02 British Dyestuffs Corp Ltd Dyestuffs of the anthraquinone series
US2411148A (en) * 1943-10-23 1946-11-19 Eastman Kodak Co Anthraquinone dyestuffs
US3960751A (en) * 1973-09-19 1976-06-01 Matsushita Electric Industrial Co., Ltd. Electro-optical display element
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4310666A (en) * 1978-04-10 1982-01-12 United States Of America Anti-neoplastic 1,4-bis-(substituted aminoalkyl amino)-anthraquinones
US4526989A (en) * 1978-07-11 1985-07-02 American Cyanamid Company 1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4598155A (en) * 1981-11-18 1986-07-01 Ciba-Geigy Corporation 3(5-tetrazolyl)1,4-diaminoanthraquinones
US4540788A (en) * 1983-07-14 1985-09-10 American Cyanamid Company Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones
DE3331296A1 (de) * 1983-08-31 1985-03-14 Hoechst Ag, 6230 Frankfurt Mono- und bisfunktionelle anthrachinon-(oxy-2,3-oxidopropane), verfahren zu ihrer herstellung und ihre verwendung
US4894451A (en) * 1985-04-01 1990-01-16 The University Of Vermont Unsymmetrical 1,4-bis(aminoalkylamino)-anthracene-9, 10-diones and derivatives
JPS6315853A (ja) * 1986-07-07 1988-01-22 Dainippon Printing Co Ltd 熱転写シ−ト用染料
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
JPH0219818A (ja) * 1988-07-07 1990-01-23 Nec Corp 暗視双眼鏡
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
GB8923075D0 (en) * 1989-10-13 1989-11-29 Patterson Laurence H Anti-cancer compounds
BR9106118A (pt) * 1990-11-02 1993-03-02 Sphinx Pharma Corp Antraquinona substituida,composicao famaceutica e processo para inibir quinase c de proteina e,uso de um composto

Also Published As

Publication number Publication date
WO1992007558A1 (en) 1992-05-14
FI923031L (fi) 1992-06-30
HUT64296A (en) 1993-12-28
HU9202207D0 (en) 1992-12-28
NO922601L (no) 1992-07-01
EP0509088A4 (en) 1993-03-24
US5141957A (en) 1992-08-25
KR920703512A (ko) 1992-12-18
NO922601D0 (no) 1992-07-01
AU9086291A (en) 1992-05-26
EP0509088A1 (en) 1992-10-21
CA2072884A1 (en) 1992-05-03
FI923031A0 (fi) 1992-06-30
FI923031A7 (fi) 1992-06-30
AU641581B2 (en) 1993-09-23
JPH05505829A (ja) 1993-08-26

Similar Documents

Publication Publication Date Title
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9106117A (pt) Antraquinona substituida,composicao farmaceutica para inibir quinase c de proteina,processo para tal inibicao e uso de um composto
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
PT90994A (pt) Processo para a preparacao de um sistema para a preparacao de composicoes para aplicacao topica
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9106118A (pt) Antraquinona substituida,composicao famaceutica e processo para inibir quinase c de proteina e,uso de um composto
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
PT97945A (pt) Processo para a preparacao de composicoes antimalarianas contendo benflumetol ederivados artemeter
BR9307523A (pt) Composto de n-alquil-gliceramida processo para sua preparação e composições
BR9506473A (pt) Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas
BR1100979A (pt) Derivado de carboidrato, processo para preparar um derivado de carboidrato, composição farmacêutica de carboidrato e uso de derivado de carboidrato
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR9103426A (pt) Compostos,processo para sua preparacao,composicoes e processo para a protecao de plantas,processo para a preparacao de composicoes e emprego
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
PT90224A (pt) Processo para a preparacao de composicoes sinergicas contendo imazalilo
BR9607264A (pt) Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR9202446A (pt) Composicao de dentifricio,dentifricio e processo para a preparacao de um dentifricio
BR9406924A (pt) Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto
BR9301107A (pt) Processo para a preparacao de um composto